Azienda Universitaria Ospedaliera Consorziale - Policlinico di Bari

Bari 70124

0 studies enrolling now · 5 studies all time

What they study most

Cluster Headache, Episodic, Low-grade Glioma, Nucleophosmin 1-mutated Acute Myeloid Leukemia, Pediatric Low-grade Glioma, Rapidly Accelerated Fibrosarcoma (RAF) Altered Glioma, SARS-CoV2 Infection, Upper Tract Urothelial Carcinomas, Urothelial Bladder Cancer

Studies at this site

• DAY101 vs. Standard of Care Chemotherapy in Pediatric Participants With Low-Grade Glioma Requiring First-Line Systemic Therapy (LOGGIC/FIREFLY-2) — Running, not enrolling
• Eptinezumab in Participants With Episodic Cluster Headache — Completed
• Oral Infigratinib for the Adjuvant Treatment of Subjects With Invasive Urothelial Carcinoma With Susceptible FGFR3 Genetic Alterations — Stopped early
• Entospletinib Plus Intensive Induction/Consolidation Chemotherapy in Newly Diagnosed NPM1-mutated AML — Stopped early
• Expanded Access Treatment Protocol: Remdesivir (RDV; GS-5734) for the Treatment of SARS-CoV2 (CoV) Infection (COVID-19) — APPROVED_FOR_MARKETING